tipifarnib has been researched along with Neurofibroma, Plexiform in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balis, FM; Belasco, J; Dombi, E; Fox, E; Gillespie, A; Goldman, S; Kieran, MW; Kim, A; Korf, BR; Martin, S; Patronas, N; Perentesis, JP; Reddy, A; Salzer, W; Solomon, J; Steinberg, SM; Widemann, BC; Wolters, PL; Wright, JJ | 1 |
| Prados, MD | 1 |
| Arceci, RJ; Balis, FM; Blaney, SM; End, D; Fox, E; Gillespie, A; Jayaprakash, N; Palumbo, JS; Pitney, A; Salzer, WL; Whitcomb, P; Widemann, BC; Zannikos, P | 1 |
| Bouffet, E; Drake, JM; Parkin, P; Rutka, JT; Serletis, D; Shroff, M | 1 |
2 trial(s) available for tipifarnib and Neurofibroma, Plexiform
| Article | Year |
|---|---|
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Cross-Over Studies; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Farnesyltranstransferase; Female; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Quinolones; Treatment Outcome; Young Adult | 2014 |
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas.
Topics: Adolescent; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Drug Administration Schedule; Drug Eruptions; Enzyme Inhibitors; Farnesyltranstransferase; Female; Gastrointestinal Tract; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Quinolones; Treatment Outcome | 2006 |
2 other study(ies) available for tipifarnib and Neurofibroma, Plexiform
| Article | Year |
|---|---|
Plexiform neurofibromas, trial design, and the definitions of "progression" and "treatment failure".
Topics: Antineoplastic Agents; Enzyme Inhibitors; Farnesyltranstransferase; Female; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Quinolones | 2014 |
Massive plexiform neurofibromas in childhood: natural history and management issues.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Cyclophosphamide; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Neurofibroma, Plexiform; Neurosurgical Procedures; Pain; Quinolones; Respiration Disorders; Retrospective Studies | 2007 |